INSM Q1 2021 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$40M+9.1% YoY

Gross Profit

$30M75.5% margin

Operating Income

-$84M-208.5% margin

Net Income

-$92M-227.9% margin

EPS (Diluted)

$-0.89

QoQ Revenue Growth

-2.9%

Cash Flow

Operating Cash Flow

-$128M

Free Cash Flow

-$129M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$692M

Total Liabilities

$491M

Stockholders' Equity

$202M

Cash & Equivalents

$410M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$37M	+9.1%
Gross Profit	$30M	$28M	+6.9%
Operating Income	-$84M	-$60M	-38.9%
Net Income	-$92M	-$66M	-38.1%